[Comparative study between 10 and 20 mg of cetirizine in the symptomatic treatment of seasonal allergic rhinoconjunctivitis] - PubMed

[Article in Spanish]

Affiliations

• PMID: 8160562

Clinical Trial

[Comparative study between 10 and 20 mg of cetirizine in the symptomatic treatment of seasonal allergic rhinoconjunctivitis]

[Article in Spanish]

J Hernández et al. Allergol Immunopathol (Madr). 1993 Sep-Oct.

Abstract

Our patients with seasonal allergic rhinoconjunctivitis usually present severe clinical symptoms. A single daily dose of cetirizine 10 mg might be insufficient for these patients. To investigate this hypothesis we compared clinical efficacy and adverse side effects between two daily doses of cetirizine, 10 and 20 mg. We designed a comparative open randomized study, including 38 patients, with hay fever sensitized to local pollens (grass, olive, parietaria judaica, chenopodium album, artemisia vulgaris and plantago lanceolata) diagnosed by clinical history and a positive skin prick test (wheal > 3 mm), 20 women and 18 men, aged 17 to 57 years (x: 31.32 +/- 9.73), living in the same geographic area. Randomly, after a week run in period, 21 subjects received a daily dose of cetirizine 10 mg during 2 weeks, and the other 17 received 10 mg twice a day. The symptomatic score used was based on: sneezes number, nasal itching, nasal secretion, nasal congestion, ocular itching, lacrimation, weight gain, sedation and additional methylprednisolone usage. All symptoms were scored on a 0-3 scale (0: absent; 1: mild; 2: moderate; 3: severe). A mean 8 points daily score during the previous week was required for recruitment. Nasal eosinophilia was determined at baseline and at the end of treatment. The study was conducted in may 1992. We did not find significant differences between the two groups, except in sneezes number and sedation. Both groups improved their symptoms, in comparison with the basal week (p < 0.01) and reduced their oral steroid use (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Similar articles

• Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.

  Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H; Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group. Corren J, et al. Clin Ther. 2005 May;27(5):543-53. doi: 10.1016/j.clinthera.2005.04.012. Clin Ther. 2005. PMID: 15978303 Clinical Trial.

• Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.

  Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R; Bilastine International Working Group. Kuna P, et al. Clin Exp Allergy. 2009 Sep;39(9):1338-47. doi: 10.1111/j.1365-2222.2009.03257.x. Epub 2009 May 4. Clin Exp Allergy. 2009. PMID: 19438584 Clinical Trial.

• Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.

  Horak F, Stübner P, Zieglmayer R, Kavina A, Corrado ME, Assandri A, Mion A. Horak F, et al. Arzneimittelforschung. 2004;54(10):666-72. doi: 10.1055/s-0031-1297019. Arzneimittelforschung. 2004. PMID: 15553106 Clinical Trial.

• Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.

  Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A. Singh-Franco D, et al. Clin Ther. 2009 Aug;31(8):1664-87. doi: 10.1016/j.clinthera.2009.08.015. Clin Ther. 2009. PMID: 19808127 Review.

• Cetirizine in allergic rhinitis.

  Kaiser HB. Kaiser HB. Pediatr Allergy Immunol. 1993;4(4 Suppl):44-6. doi: 10.1111/j.1399-3038.1993.tb00338.x. Pediatr Allergy Immunol. 1993. PMID: 8353659 Review. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information